Here we report the functional consequences of EPHA1 missense mutations identified in Alzheimer’s disease patients, including impaired EPHA1 trafficking, decreased protein stability, and dysregulated canonical and/or noncanonical signaling (Fig. 7). Here, EPHA1 is linked to Alzheimer disease.